Bioprocess Automation: Truth Or Illusion?

iBio COO Randy Maddux, Kyowa Kirin, EVP of Operations and Supply Chain Paul Testa, and Sutro Biopharma VP of Manufacturing and Plant Operations Devendra Luhar joined Matt Pillar, Chief Editor of Bioprocess Online for a spirited, interactive discussion on aversions to biopharma manufacturing automation, the technology, cost, and implementation challenges it presents, and why you should commit to it anyway.  Actionable insights include the stepwise, cost-conscious approaches the panelists are taking to improving quality control and data integrity through automation.